Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administration

Immunogenicity of AAV vectors renders repeated AAV dosing ineffective. Here the authors show that coadministration of nanoparticle-encapsulated rapamycin overcomes AAV immunogenicity through Treg induction, enabling efficient AAV redosing in mice and nonhuman primates.

מידע ביבליוגרפי

Principais autores:	Amine Meliani, Florence Boisgerault, Romain Hardet, Solenne Marmier, Fanny Collaud, Giuseppe Ronzitti, Christian Leborgne, Helena Costa Verdera, Marcelo Simon Sola, Severine Charles, Alban Vignaud, Laetitia van Wittenberghe, Giorgia Manni, Olivier Christophe, Francesca Fallarino, Christopher Roy, Alicia Michaud, Petr Ilyinskii, Takashi Kei Kishimoto, Federico Mingozzi
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Nature Portfolio 2018-10-01
סדרה:	Nature Communications
גישה מקוונת:	https://doi.org/10.1038/s41467-018-06621-3
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!